Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction.

Match Day at Vanderbilt University School of Medicine (VUSM) has grown so popular the event moved from its traditional lecture hall setting at Light Hall to the more-spacious Langford Auditorium.

Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer.

There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine.

A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors.

Severe weather in Nashville March 18 prompted the sounding of Metropolitan Nashville’s sirens and also prompted some questions about Vanderbilt’s notification system.

The latest Credo Award and Five Pillar Leader Award winners were announced at this week’s Spring Clinical Enterprise Leadership Assembly at Langford Auditorium.